m6A-centered Disease Response Information
General Information of the Disease (ID: M6ADIS0165)
Name |
Skin tumour
|
||||
---|---|---|---|---|---|
ICD |
ICD-11: 2F92
|
Full List of Target Gene(s) of This m6A-centered Disease Response
DNA damage-binding protein 2 (DDB2)
In total 1 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | METTL14 knockdown decreases GGR and DNA damage-binding protein 2 (DDB2) abundance. Conversely, overexpression of wild-type METTL14 but not its enzymatically inactive mutant increases GGR and DDB2 abundance. METTL14 is a target for selective autophagy and acts as a critical epitranscriptomic mechanism to regulate GGR and suppress UVB-induced skin tumorigenesis. | |||
Responsed Disease | Skin tumour [ICD-11: 2F92] | |||
Target Regulator | Methyltransferase-like 14 (METTL14) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | Nucleotide excision repair | hsa03420 | ||
Cell Process | Genome repair | |||
Cell autophagy | ||||
In-vitro Model | NHEK (Normal human epithelial keratinocytes) | |||
MEF (Mouse embryonic fibroblasts) | ||||
HaCaT | Normal | Homo sapiens | CVCL_0038 | |
A-431 | Skin squamous cell carcinoma | Homo sapiens | CVCL_0037 | |